Indias first COVID-19 vaccine candidate has anti-rejection drug

Indias first brand of a potential COVID-19 vaccine candidate was launched on Thursday with its promoters ScRio and APIMA labeling it as an indocyanine agent (IGA). The Dexamethasone brand is launched by the Indian Council of Medical Research (ICMR) and the Indian Drugs Controllers Association (IDC). We are full-time on research development production purchase and supply of Dexamethasone B brand vaccine candidate. Testing (of the vaccine candidate candidate) has commenced. If it proves to be effective it is accepted as a game changer in the COVID-19 main arena and an acquired taste that would be very helpful. A good news about this product is that it is already being used by the state of Maharashtra to contain the governors emergency said Mr Adarsh Yadav the chief health officer of Maharashtra state.

He said there was no chance of shortage of the vaccine candidate due to the rushed path taken by the manufacturer to make it available.

The earlier Dexamethasone came under the scanner after a farmers strike last year resulted in the cancellation of millions of cattle sheep buffalo and camels for a year.

Governments in many parts of the world were said to have moved towards vaccinating their people with weakened immune systems as a result of last years severe coronavirus outbreak.